Search Results - "Duso, B.A."

1690P - Comparison of filgrastim and pegfilgrastim prophylaxis in sarcoma patients receiving highly myelosuppressive chemotherapy by Tarantino, P., Zagami, P., Trillo, P., Conforti, F., Pala, L., Morganti, S., Ferraro, E., Viale, G., Duso, B.A., D’Amico, P., Marra, A., Trapani, D., De Pas, T.M.

“…Highly myelosuppressive chemotherapy (HMC) is the standard treatment for several types of sarcoma. Severe neutropenia is a common adverse event, which can lead…”
Get full text

Comparison of filgrastim and pegfilgrastim prophylaxis in sarcoma patients receiving highly myelosuppressive chemotherapy by Tarantino, P., Zagami, P., Trillo, P., Conforti, F., Pala, L., Morganti, S., Ferraro, E., Viale, G., Duso, B.A., D’Amico, P., Marra, A., Trapani, D., De Pas, T.M.

Get full text

Secondary mechanisms of anti-HER2 resistance in breast cancer: NF1 as an actionable target by Duso, B.A., Poletti, C., Curigliano, G., Pelicci, P.G., Mazzarella, L.

Get full text

Quantifying geographical accessibility to cancer clinical trials in different income landscapes by Tini, G., Trapani, D., Duso, B.A., Beria, P., Curigliano, G., Pelicci, P.G., Mazzarella, L.

“…Clinical trials are increasingly perceived as a therapeutic opportunity for cancer patients. Favoring their concentration in few high-expertise academic…”
Get full text

Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial by de Guillebon, E., Jimenez, M., Mazzarella, L., Betsou, F., Stadler, P., Peták, I., Jeannot, E., Chanas, L., Servant, N., Marret, G., Duso, B.A., Legrand, F., Kornerup, K.N., Bernhart, S.H., Balogh, G., Dóczi, R., Filotás, P., Curigliano, G., Bièche, I., Guérin, J., Dirner, A., Neuzillet, C., Girard, N., Borcoman, E., Larbi Chérif, L., Tresca, P., Roufai, D.B., Dupain, C., Scholl, S., André, F., Fernandez, X., Filleron, T., Kamal, M., Le Tourneau, C.

“…Squamous cell carcinomas (SCCs) are among the most frequent solid tumors in humans. SCCs, related or not to the human papillomavirus, share common molecular…”
Get full text